[Anti-arteriosclerosis effects due to stimulation of endogenous nitric oxide synthesis].
Bode-Böger
S M
SM
Institut für Klinische Pharmakologie, Medizinische Hochschule Hannover.
Böger
R H
RH
Frölich
J C
JC
D000328:Adult; D000818:Animals; D001120:Arginine / Q000009:adverse effects / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000502:physiology*; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use
D014665:Vasodilator Agents; D009569:Nitric Oxide; D001120:Arginine; D019001:Nitric Oxide Synthase